title: Is the use of t-PA as compared with streptokinase cost effective?
authors.forename: E A
authors.initials: EA
authors.lastname: Rose
mesh_terms: D003362:Cost-Benefit Analysis; D006801:Humans; D008017:Life Expectancy; D009203:Myocardial Infarction / Q000188:drug therapy*; D013300:Streptokinase / Q000627:therapeutic use*; D015912:Thrombolytic Therapy / Q000191:economics*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D013300:Streptokinase; D010959:Tissue Plasminogen Activator